Does stem cell therapy help women get over menopause?
Stem cell therapy does not stop or reverse menopause, and it does not replace hormone therapy, which remains the most effective treatment for hot flashes and night sweats.

What regenerative treatment can do is support some of the physical changes many women experience around and after menopause: joint pain and stiffness, which become more common as estrogen declines; lower energy and slower recovery; and changes in skin and hair. By reducing inflammation and supporting the body's repair processes, allogeneic mesenchymal stem cells (MSCs) from Wharton's jelly of the umbilical cord may help women feel and function better during this stage. At Stem Cell Mexico, menopause support protocols are individualized, usually by intravenous (IV) infusion, sometimes combined with local treatment of painful joints, scalp or skin, and typically cost $6,000 to $8,000 USD. Treatment works alongside your gynecologist's care, and results vary from woman to woman.
This guide explains what changes during menopause, which symptoms regenerative treatment can and cannot address, and how to build a complete plan for this stage of life.
What happens during menopause
Menopause is the natural end of menstrual periods, confirmed after 12 months without a period, usually between 45 and 55. In the years before and after, known as perimenopause and postmenopause, estrogen and progesterone levels fall. According to the NICE guideline on menopause (NG23), common symptoms include:
- Vasomotor symptoms: hot flashes and night sweats.
- Sleep problems.
- Mood changes, such as irritability, low mood or anxiety.
- Joint and muscle pain and stiffness.
- Vaginal dryness and discomfort, and changes in sexual desire.
- Changes in skin and hair, such as dryness, thinning and loss of elasticity.
- Changes in concentration and memory, often described as brain fog.
Over the longer term, lower estrogen also affects bone density and cardiovascular health. Symptoms vary widely: some women have few, while others find that symptoms affect work, sleep, relationships and quality of life for several years.
Proven treatments come first
NICE recommends individualized care that may include:
- Hormone replacement therapy (HRT), the most effective treatment for vasomotor symptoms, with benefits and risks discussed individually.
- Vaginal estrogen for local symptoms.
- Non-hormonal medications for women who cannot or prefer not to use hormones.
- Cognitive behavioral therapy for mood, sleep and vasomotor symptoms.
- Lifestyle measures: exercise, weight management, limiting alcohol and caffeine, not smoking.
Regenerative treatment is added to this care; it is not a substitute for hormone therapy or for evaluation by your gynecologist. Many women use both: hormone or non-hormonal treatment for hot flashes, sleep and vaginal symptoms, and regenerative treatment for joints, energy, hair or skin.
Where regenerative treatment can help
Joint pain and stiffness
Joint pain is one of the most common physical complaints in menopause, and osteoarthritis becomes more frequent in women after this stage. For knee osteoarthritis, a 2024 meta-analysis of randomized trials in the Journal of Orthopaedic Translation found that MSC injections reduced pain more than hyaluronic acid at 12 months and improved function. Local joint treatment can be combined with an IV protocol in the same visit.
Energy, recovery and age-related inflammation
A randomized, placebo-controlled trial in older adults with frailty, published in the Journals of Gerontology, found better walking distance and lower inflammatory markers after allogeneic MSC infusions, supporting the concept of reducing age-related inflammation. Some women report more energy and better recovery after an IV protocol.
Skin and hair
Regenerative scalp protocols, which combine cells and platelet-rich plasma (PRP), are used for hair thinning, and some women seek regenerative treatment, including exosomes, for skin texture and firmness.
What it does not treat
- Hot flashes and night sweats, which respond best to hormone therapy or specific non-hormonal treatments.
- Depression or anxiety disorders, which need specific evaluation and care.
- Bone loss, which requires assessment and, when indicated, bone-protective treatment.
How MSCs work
MSCs from Wharton's jelly act through paracrine signaling: they release anti-inflammatory and trophic factors that may calm inflammation, support the repair activity of your own cells and promote the health of small blood vessels. These effects are general, which is why IV protocols are used for systemic goals such as energy and recovery, and local applications for specific problems such as a painful knee.
What our patients usually receive
Based on the treatment plans our team prepares for women, typical protocols at Stem Cell Mexico include:
- For systemic goals: Wharton's jelly MSCs by IV infusion, usually between 100 and 200 million cells, depending on body weight and medical review.
- For a painful joint: 20 to 40 million cells by direct injection with ultrasound guidance, often with PRP.
- For hair: cells and PRP applied to the scalp.
- One night at our facilities with nursing and medical monitoring, the consultation with your doctor and the stem cell specialist, pre-treatment laboratory tests and ground transportation from the San Diego airport area.
Menopause support protocols typically cost $6,000 to $8,000 USD; one joint $3,900 to $6,000 USD; and hair protocols $1,800 to $3,500 USD. Combined goals are quoted together.
Recovery is gradual, and each woman responds differently. Some notice changes within the first weeks, while others notice them over the following months. Our team stays in contact after treatment to follow your progress.
Building a complete plan for menopause
- See your gynecologist to discuss hormone therapy or non-hormonal options for vasomotor symptoms.
- Check bone health with a bone density scan when recommended.
- Review cardiovascular risk: blood pressure, cholesterol and blood sugar.
- Exercise regularly, including strength training, which supports bones, joints, mood and sleep.
- Protect sleep with a regular schedule, a cool bedroom and limited screens before bed.
- Add regenerative treatment for specific goals such as joint pain, energy, hair or skin.
How to measure what changes
- Joint pain: 0 to 10 score and activities you can do.
- Energy: daily rating or a fatigue questionnaire.
- Sleep: hours and awakenings.
- Hair and skin: standardized photographs.
- Overall well-being: a validated menopause symptom questionnaire, such as the Menopause Rating Scale.
Recording these before treatment and at one, three and six months shows clearly what changed.
What women commonly report
When regenerative treatment is matched to a clear goal, women usually describe practical changes: less knee or hand pain when walking, gardening or exercising, less morning stiffness, more energy in the afternoon, better recovery after exercise and, over several months, fuller-looking hair or improved skin texture. Some notice clear changes, others modest ones. Comparing your own measures before and after treatment is the best way to see your result.
Questions women often ask
Can I continue my hormone therapy? Yes. Hormone therapy and regenerative treatment can be used together, and your gynecologist remains in charge of hormone decisions.
Will it improve my libido or vaginal dryness? These symptoms are best treated with specific options such as vaginal estrogen, lubricants and, when indicated, other treatments discussed with your gynecologist. Regenerative treatment is not designed for them.
Is there an ideal time during menopause? There is no single ideal time. Treatment is planned around your goals, such as joint pain or energy, whether you are in perimenopause or years after menopause.
Can I travel alone? Yes. Many women travel alone; our driver meets you in the San Diego airport area and the team accompanies you throughout the visit.
Safety
Large meta-analyses of IV MSC trials, including a 2026 analysis focused on umbilical-cord-derived MSCs in Stem Cells Translational Medicine, found temporary fever as the most consistent side effect, without an increase in serious infection, thrombosis, cancer or death in controlled trials. Women with a history of blood clots, hormone-sensitive cancers or other conditions are reviewed carefully. Regenerative treatments are not performed during pregnancy or breastfeeding. No treatment is free of risk.
Who may be a candidate
- Women in perimenopause or postmenopause with specific goals, such as joint pain, energy, hair or skin.
- Stable general health, with chronic conditions under control.
- No active infection and no cancer within the past five years.
- Ongoing care with a gynecologist or primary care physician, who remains in charge of hormone decisions.
Questions to ask during your evaluation
- Which of my symptoms can regenerative treatment realistically support?
- Should I discuss hormone therapy with my gynecologist first?
- Can I combine an IV protocol with joint or hair treatment?
- How will we measure results, and when should I expect changes?
Bottom line
Stem cell therapy does not stop menopause or replace hormone therapy, but it can support joint pain, energy, recovery, hair and skin, which are among the changes many women experience at this stage. At Stem Cell Mexico, Wharton's jelly MSCs are used as part of a complete plan with your gynecologist, and results vary from woman to woman. A medical evaluation can help determine whether this type of regenerative treatment is appropriate for your goals, health and medical history.
References
- NICE guideline NG23: Menopause, identification and management (opens in a new tab)
- Tabet CG et al. Advanced therapy with mesenchymal stromal cells for knee osteoarthritis: systematic review and meta-analysis of randomized controlled trials. Journal of Orthopaedic Translation, 2024 (opens in a new tab)
- Tompkins BA et al. Allogeneic mesenchymal stem cells ameliorate aging frailty: a phase II randomized, double-blind, placebo-controlled clinical trial. The Journals of Gerontology, Series A, 2017 (opens in a new tab)
- Hum C et al. Safety of intravascular administration of umbilical-cord-derived mesenchymal stromal cells: an updated systematic review and meta-analysis. Stem Cells Translational Medicine, 2026 (opens in a new tab)
